TECTONIC THERAPEUTIC, INC. Payments of Debt Issuance Costs
TECTONIC THERAPEUTIC, INC. (TECX) reported Payments of Debt Issuance Costs of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2023-03-23
- TECTONIC THERAPEUTIC, INC. payments of debt issuance costs for the quarter ending 2017-12-31 was $0.00.
- TECTONIC THERAPEUTIC, INC. payments of debt issuance costs for the quarter ending 2017-09-30 was $12.00K.
- TECTONIC THERAPEUTIC, INC. payments of debt issuance costs for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- TECTONIC THERAPEUTIC, INC. payments of debt issuance costs for fiscal 2021 was $103.00K.
- TECTONIC THERAPEUTIC, INC. payments of debt issuance costs for fiscal 2017 was $44.00K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-23 | |||
| 2021-12-31 | $103.00K 10-K · filed 2023-03-23 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $12.00K derived: sum of 2 quarters · filed 2019-03-25 | $44.00K 10-K · filed 2019-03-25 | |
| 2017-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $44.00K 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | $32.00K 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |